Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Carcinomatosis: Higher Complication Rate for Oxaliplatin Compared to Mitomycin C

References

• Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80 (6): 827–41.
   Google Scholar
• Chu D. Z., Lang N. P., Thompson C., Osteen P. K., Westbrook K. C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer, 1989, 63 (2): 364–7.
   Google Scholar
• Sadeghi B., Arvieux C., Glehen O. et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer, 2000, 88 (2): 358–63.
   Google Scholar
• Sugarbaker P. H., Cunliffe W. J., Belliveau J. et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol, 1989, 16 (4 Suppl 6): 83–97.
   Google Scholar
• Elias D., Blot F., El Otmany A. et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer, 2001, 92 (1): 71–6.
   Google Scholar
• Detroz B., Laurent S., Honore P. et al. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis. Acta Chir Belg, 2004, 104 (4): 377–83.
   Google Scholar
• Elias D., Matsuhisa T., Sideris L. et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol, 2004, 15 (10): 1558–65.
   Google Scholar
• Sugarbaker P. H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcino-matosis and sarcomatosis. Semin Surg Oncol, 1998, 14 (3): 254–61.
   Google Scholar
• Shen P., Hawksworth J., Lovato J. et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol, 2004, 11 (2): 178–86.
   Google Scholar
• Sugarbaker P. H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol, 1999, 43 Suppl: S15–S25.
   Google Scholar
• Sugarbaker P. H., Schellinx M. E., Chang D., Koslowe P., von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg, 1996, 20 (5): 585–91.
   Google Scholar
• Eilber F. C., Rosen G., Forscher C. et al. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol, 1999, 6 (7): 645–50.
   Google Scholar
• Haller D. G. Chemotherapy in gastrointestinal malignancies. Semin Oncol, 1988, 15 (3 Suppl 4): 50–64.
   Google Scholar
• Storm F. K. Clinical hyperthermia and chemotherapy. Radiol Clin North Am, 1989, 27 (3): 621–7.
   Google Scholar
• Andre T., Boni C., Mounedji-Boudiaf L. et al. Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon cancer. NEngl JMed, 2004, 350 (23): 2343–51.
   Google Scholar
• Pestieau S. R., Belliveau J. F., Griffin H. etal. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Surg Oncol, 2001, 76 (2): 106–14.
   Google Scholar
• Elias D., Bonnay M., Puizillou J. M. et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol, 2002, 13 (2): 267–72.
   Google Scholar
• Elias D., Sideris L., Pocard M. et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal car-cinomatosis. Preliminary results in 24 patients. Ann Oncol, 2004, 15 (5): 781–5.
   Google Scholar
• Verwaal V. J., van Tinteren H., Ruth S. V. et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol, 2004, 85 (2): 61–7.
   Google Scholar
• Makrin V., Lev-Chelouche D., Even Sapir E. et al. Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. J Surg Oncol, 2005, 89 (1): 18–22.
   Google Scholar
• van der Kolk B. M., de Man B. M., Wobbes T. et al. Is early postoperative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine ? Br J Cancer, 1999, 79 (34): 545–50.
   Google Scholar
• Dindo D., Demartines N., Clavien P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004, 240 (2): 205–13.
   Google Scholar
• Glehen O., Kwiatkowski F., Sugarbaker P. H. et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: amulti-institutional study. J Clin Oncol, 2004, 22 (16): 3284–92.
   Google Scholar